WHO receives positive feedback on BQ for biologicals

posted 27/04/2015

According to the World Health Organization’s executive summary of its 59th Consultation on International Nonproprietary Names (INNs) for Pharmaceutical Subst...

Promoting generics prescribing in the US Biosimilars/Research | Posted 27/04/2015
US health insurance CMS outlines biosimilar policy Policies & Legislation | Posted 27/04/2015
Poland’s experience with generic imatinib Generics/Research | Posted 27/04/2015
Samsung adds 48-week extension to SB4 biosimila... Biosimilars/News | Posted 27/04/2015
Soaring generics prices come under increased sc... Generics/General | Posted 27/04/2015
Generics group established first voice for bios... Biosimilars/General | Posted 27/04/2015
Growing investment in Vietnam Pharma News | Posted 27/04/2015
Arguments for same INN for biosimilars presente... Biosimilars/General | Posted 17/04/2015
More US state legislation on biosimilars substi... Policies & Legislation | Posted 17/04/2015
Safety and cost considerations of generic and o... Generics/Research | Posted 17/04/2015
Substitution of biosimilars in the US Biosimilars/Research | Posted 17/04/2015
IDT Australia gets FDA nod for 23 generics Generics/News | Posted 17/04/2015
Merck outlines biosimilars programme Biosimilars/News | Posted 17/04/2015
Dutch medicines agency says biosimilars ‘have n... Biosimilars/General | Posted 10/04/2015
Substitution of generics in the US Biosimilars/Research | Posted 10/04/2015
Infliximab SEB launched in Canada Biosimilars/News | Posted 10/04/2015
Brazilian patients positive about generics Generics/Research | Posted 10/04/2015
Regulations for biosimilars in South Korea Guidelines | Posted 10/04/2015
Effectiveness of generic and originator gabapen... Generics/Research | Posted 10/04/2015
France outlines plans to promote generics Generics/General | Posted 10/04/2015
21st EGA Annual Conference Conferences | Posted 10/04/2015
Comparison of the markets for biosimilars and g... Biosimilars/Research | Posted 03/04/2015
Comparison of generic and originator gabapentin Generics/Research | Posted 03/04/2015
Patient registry data supports efficacy and saf... Biosimilars/Research | Posted 03/04/2015
FDA guidance on excipients questioned Guidelines | Posted 03/04/2015
Samsung Bioepsis submits second biosimilar to EMA Biosimilars/News | Posted 03/04/2015
India to set up pharma manufacturing clusters Pharma News | Posted 03/04/2015
Shire grabs Par’s attention with patent lawsuit Generics/News | Posted 03/04/2015
Dr Reddy’s US drug pricing comes under scrutiny Generics/General | Posted 03/04/2015
Generics utilization policies necessary to sust... Generics/Research | Posted 27/03/2015
Paying physicians to prescribe generics and bio... Biosimilars/Research | Posted 27/03/2015
US court rejects Amgen’s bid to block filgrasti... Biosimilars/News | Posted 27/03/2015
Drug manufacturers call for revision to FDA saf... Policies & Legislation | Posted 27/03/2015
Rheumatologists want to evaluate long-term safe... Biosimilars/General | Posted 27/03/2015
Actavis loses Atelvia patents Generics/News | Posted 27/03/2015
Survey among pharmacists shows high confidence... Biosimilars/Research | Posted 20/03/2015
Biosimilars of filgrastim Biosimilars/General | Posted 20/03/2015
Health Canada clamps down on GMP compliance Generics/General | Posted 20/03/2015
Infliximab biosimilars tighten grip on European... Biosimilars/News | Posted 20/03/2015
California and Illinois consider biosimilar sub... Policies & Legislation | Posted 20/03/2015
Ranbaxy fails to reverse FDA decision over Valc... Generics/News | Posted 20/03/2015
FDA approves its first biosimilar Biosimilars/News | Posted 13/03/2015

Generics News Research General


Biosimilars News Research General